Select Publications
Book Chapters
2019, 'Cancer Methylation Biomarkers in Circulating Cell-Free DNA', in Clinical Epigenetics, pp. 217 - 245, http://dx.doi.org/10.1007/978-981-13-8958-0_10
,Journal articles
2024, 'Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling', BMC Genomics, 25, http://dx.doi.org/10.1186/s12864-024-10027-5
,2024, 'Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma', Journal of Pathology, 262, pp. 480 - 494, http://dx.doi.org/10.1002/path.6250
,2024, 'The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer', Nature Structural and Molecular Biology, 31, pp. 498 - 512, http://dx.doi.org/10.1038/s41594-023-01181-7
,2024, 'Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma', Pathology, 56, pp. S70 - S71, http://dx.doi.org/10.1016/j.pathol.2023.12.241
,2023, 'A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer', Nature Cancer, 4, pp. 1326 - 1344, http://dx.doi.org/10.1038/s43018-023-00614-y
,2022, 'Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality', CLINICAL AND TRANSLATIONAL MEDICINE, 12, http://dx.doi.org/10.1002/ctm2.1030
,2021, 'Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer', Clinical Epigenetics, 13, http://dx.doi.org/10.1186/s13148-021-01210-6
,2021, 'MethPanel: a parallel pipeline and interactive analysis tool for multiplex bisulphite PCR sequencing to assess DNA methylation biomarker panels for disease detection', Bioinformatics, 37, pp. 2198 - 2200, http://dx.doi.org/10.1093/bioinformatics/btaa1060
,2020, 'Advances in Prognostic Methylation Biomarkers for Prostate Cancer', , http://dx.doi.org/10.20944/preprints202010.0154.v1
,2020, 'Advances in prognostic methylation biomarkers for prostate cancer', Cancers, 12, pp. 1 - 39, http://dx.doi.org/10.3390/cancers12102993
,2020, 'Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels', Clinical Epigenetics, 12, http://dx.doi.org/10.1186/s13148-020-00880-y
,2020, 'Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer', Clinical Epigenetics, 12, http://dx.doi.org/10.1186/s13148-020-00836-2
,2019, 'Evaluation of cross-platform and interlaboratory concordance via consensus modelling of genomic measurements', Bioinformatics, 35, pp. 560 - 570, http://dx.doi.org/10.1093/bioinformatics/bty675
,2019, 'DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns', Cancer Cell, 35, pp. 297 - 314.e8, http://dx.doi.org/10.1016/j.ccell.2019.01.004
,2018, 'Enduring epigenetic landmarks define the cancer microenvironment', Genome Research, 28, pp. 625 - 638, http://dx.doi.org/10.1101/gr.229070.117
,2018, 'Using the epigenome to understand and better classify phyllodes tumours', Pathology, 50, pp. S7 - S8, http://dx.doi.org/10.1016/j.pathol.2017.12.015
,2017, 'Mitochondrial genes are altered in blood early in Alzheimer's disease', Neurobiology of Aging, 53, pp. 36 - 47, http://dx.doi.org/10.1016/j.neurobiolaging.2016.12.029
,2017, 'Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer', Oncogene, 36, pp. 1328 - 1338, http://dx.doi.org/10.1038/onc.2016.297
,2017, 'Schizophrenia-associated methylomic variation: Molecular signatures of disease and polygenic risk burden across multiple brain regions', Human Molecular Genetics, 26, pp. 210 - 225, http://dx.doi.org/10.1093/hmg/ddw373
,2016, 'Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling', Genome Biology, 17, pp. 208, http://dx.doi.org/10.1186/s13059-016-1066-1
,2016, 'Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling', GENOME BIOLOGY, 17, http://dx.doi.org/10.1186/s13059-016-1066-1
,2016, 'Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas', Clinical Epigenetics, 8, http://dx.doi.org/10.1186/s13148-016-0235-0
,2016, 'DNA methylation profiles in preeclampsia and healthy control placentas', American Journal of Physiology - Heart and Circulatory Physiology, 310, pp. H1295 - H1303, http://dx.doi.org/10.1152/ajpheart.00958.2015
,2015, 'Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci', Nature Neuroscience, 19, pp. 48 - 54, http://dx.doi.org/10.1038/nn.4182
,2015, 'Correction To: Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes (PLoS Genet, 11, 11)', PLoS Genetics, 11, http://dx.doi.org/10.1371/journal.pgen.1005682
,2015, 'DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer', Nature Communications, 6, http://dx.doi.org/10.1038/ncomms8758
,2015, 'Oestrogen receptor α promotes prostate cancer progression through dual actions in both epithelia and stroma', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.37.oc8.5
,2015, 'De novo identification of differentially methylated regions in the human genome', Epigenetics and Chromatin, 8, http://dx.doi.org/10.1186/1756-8935-8-6
,2015, 'Methylomic analysis of monozygotic twins discordant for childhood psychotic symptoms', Epigenetics, 10, pp. 1014 - 1023, http://dx.doi.org/10.1080/15592294.2015.1099797
,2015, 'ISDN2014_0171: Dynamic and sex‐specific changes in DNA methylation during human fetal brain development', International Journal of Developmental Neuroscience, 47, pp. 50 - 51, http://dx.doi.org/10.1016/j.ijdevneu.2015.04.142
,2015, 'PO-097: Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas', Radiotherapy and Oncology, 114, pp. 49 - 49, http://dx.doi.org/10.1016/s0167-8140(15)34857-x
,2014, 'Epigenomic and transcriptomic signatures of a Klinefelter syndrome (47,XXY) karyotype in the brain', Epigenetics, 9, pp. 587 - 599, http://dx.doi.org/10.4161/epi.27806
,2014, 'Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia', Genome Biol, 15, pp. 483, http://dx.doi.org/10.1186/PREACCEPT-1621721621132088
,2014, 'Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia', Genome Biology, 15, pp. 483 - 483, http://dx.doi.org/10.1186/preaccept-1621721621132088
,2013, 'A data-driven approach to preprocessing Illumina 450K methylation array data', BMC Genomics, 14, http://dx.doi.org/10.1186/1471-2164-14-293
,2013, 'Epigenetic studies of schizophrenia: Progress, predicaments, and promises for the future', Schizophrenia Bulletin, 39, pp. 11 - 16, http://dx.doi.org/10.1093/schbul/sbs139
,2013, 'Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes', PLoS Genetics, 9, http://dx.doi.org/10.1371/journal.pgen.1003094
,2012, 'DNA methylation at the Igf2/H19 imprinting control region is associated with cerebellum mass in outbred mice', Molecular Brain, 5, http://dx.doi.org/10.1186/1756-6606-5-42
,2012, 'Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population', PLoS Genetics, 8, http://dx.doi.org/10.1371/journal.pgen.1002629
,2012, 'Epigenetic and genetic variation at the IGF2/H19 imprinting control region on 11p15.5 is associated with cerebellum weight', Epigenetics, 7, pp. 155 - 163, http://dx.doi.org/10.4161/epi.7.2.18910
,2012, 'Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood.', Genome biology, 13, http://dx.doi.org/10.1186/gb-2012-13-6-r43
,2012, 'Poster #105 MONOZYGOTIC TWINS DISCORDANT FOR BIPOLAR DISORDER SHOW FUNCTIONAL DNA METHYLATION CHANGES IN WHOLE BLOOD AND BRAIN', Schizophrenia Research, 136, pp. S129 - S129, http://dx.doi.org/10.1016/s0920-9964(12)70420-6
,2011, 'Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder', Human Molecular Genetics, 20, pp. 4786 - 4796, http://dx.doi.org/10.1093/hmg/ddr416
,Conference Papers
2017, 'Abstract 1997: Charting the DNA methylation landscape of prostate cancer associated fibroblasts', in Cancer Research, American Association for Cancer Research (AACR), pp. 1997 - 1997, http://dx.doi.org/10.1158/1538-7445.am2017-1997
,Conference Abstracts
2018, 'When Focal Therapy Fails for Localised Prostate Cancer - Can Epigenetics Predict Which Patients Fail and Improve Patient Selection?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 14, pp. 33 - 33, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437670700023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Mining the microenvironment methylome to identify novel prostate cancer biomarkers', in Prostate Cancer, Hindawi Publishing Corporation, Brisbane, presented at Prostate Cancer Collaborative Symposium, Brisbane, 26 November 2015 - 28 November 2015
,2015, 'Charting the epigenomic landscape of the prostate cancer microenvironment', in Epigenetics, Taylor & Francis: STM, Behavioural Science and Public Health Titles, Hobart, presented at Illumina Early Career Awards, Hobart, 12 November 2015 - 14 November 2015
,2015, 'Surveying the epigenome landscape of the prostate cancer microenvironment: identification of estrogen receptor alpha as a key differentially methylated gene', in CLINICAL ENDOCRINOLOGY, WILEY, AUSTRALIA, Adelaide, Vol. 84, pp. 20 - 20, presented at Annual Scientific Meeting of the Endocrine-Society-of-Australia, AUSTRALIA, Adelaide, 23 August 2015 - 26 August 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000372310400056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Peeling back the layers of the Prostate Cancer microenvironment', in ASMR, ASMR 23rd NSW Annual Scientific Meeting, Sydney, presented at ASMR 23rd NSW Annual Scientific Meeting, Sydney, 01 June 2015 - 02 June 2015
,